Stock 002082 WANBANGDE PHARMACEUTICAL HOLDING GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Wanbangde Pharmaceutical Holding Group Co., Ltd.

Equities

002082

CNE000001P94

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 30/06/2024 BST 		5-day change 1st Jan Change
4.28 CNY +1.66% Intraday chart for Wanbangde Pharmaceutical Holding Group Co., Ltd. +2.88% -33.12%
06-24 Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) dropped from S&P Global BMI Index CI
05-08 US FDA Gives Rare Pediatric Disease Drug Designation to Wanbangde Pharmaceutical's Huperzine A MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Proposes Final Cash Dividend for the Year 2023
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Wanbangde Pharma's Anesthesia Passes Drug Regulator's Consistency Evaluation
MT
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Cash Dividend for the Year 2022
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Announces Final Profit Distribution Proposal for 2022
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Wanbangde Pharma in Talks to Buy Controlling Stake in Consun Pharma
MT
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Plan announced on March 15, 2021.
CI
Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback announced on March 15, 2021, has expired with 5,000,000 shares, representing 0.81% for CNY 59.98 million.
CI
Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Plan announced on March 15, 2021.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 002082 Stock
  4. News Wanbangde Pharmaceutical Holding Group Co., Ltd.
  5. Highlights